Fibroblast Migration on Fibronectin Requires Three Distinct Functional Domains

Journal of Investigative Dermatology

Volumn 121, Issue 4, 2003, Pages 695-705

  Clark, Richard A F ^a,c   An, Jian Qiang ^a   Greiling, Doris ^a   Khan, Azim ^a   Schwarzbauer, Jean E ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b PRINCETON UNIVERSITY   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

25 1; Cell migration; Wound healing; 4 1

Indexed keywords

FIBRONECTIN; HEPARIN; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; MESENCHYME; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; SKIN FIBROBLAST; WOUND; WOUND HEALING;

EID: 0141991199     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12484.x     Document Type: Article

References (68)

1. Aguirre KM, McCormick RJ, Schwarzbauer JE: Fibronectin self-association is mediated by complementary sites within the amino-terminal one-third of the molecule. J Biol Chem 269:27863-27868, 1994
2. Akiyama SK, Aota S, Yamada KM: Function and receptor specificity of a minimal 20 kilodalton cell adhesive fragment of fibronectin. Cell Adhes Commun 3:13-25, 1995
3. Akiyama SK, Yamada SS, Chen W-T, Yamada KM: Analysis of fibronectin receptor function with monoclonal antibodies: Roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J Cell Biol 109:863-875, 1989
4. Barkalow FJ, Schwarzbauer JE: Interactions between fibronectin and chondroitin sulfate are modulated by molecular context. J Biol Chem 269:3957-3962, 1994
5. Barkalow FJ, Schwarzbauer JE: Localization of the major heparin-binding site in fibronectin. J Biol Chem 266:7812-7818, 1991
6. Beauvais A, Erickson CA, Goins T, Craig SE, Humphries MJ, Thiery JP, Dufour S: Changes in the fibronectin-specific integrin expression pattern modify the migratory behavior of sarcoma S180 cells in vitro and in the embryonic environment. J Cell Biol 128:699-713, 1995
7. Bloom L, Ingham KC, Hynes RO: Fibronectin regulates assembly of actin filaments and focal contacts in cultured cells via the heparin-binding site in repeat III13. Mol Biol Cell 10:1521-1536, 1999
8. Busby TF, Argraves WS, Brew SA, Pechik I, Gilliland GL, Ingham KC: Heparin binding by fibronectin module III-13 involves six discontinuous basic residues brought together to form a cationic cradle. J Biol Chem 270:18558-18562, 1995
9. Chan BM, Kassner PD, Schiro JA, Byers R, Kupper TS, Hemler ME: Distinct cellular functions mediated by different VLA integrin α subunit cytoplasmic domains. Cell 68:1051-1060, 1992
10. Chrzanowska-Wodnicka M, Burridge K: Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol 133:1403-1415, 1996
11. Clark RAF: Wound repair: Overview and general considerations. In: Clark R (ed.) Molecular and Cellular Biology of Wound Repair. New York: Plenum Press, 1996; p3-50
12. Clark RAF, Lin F, Greiling D, Couchman JR: Fibroblast invasive migration into fibronectin/fibrin gels requires dermatan sulfate-CD44 proteoglycan. J Invest Dermatol, 2003: in press
13. Deutsch DG, Mertz ET: Plasminogen: Purification from human plasma by affinity chromatography. Science 170:1095-1096, 1970
14. Drake SL, Klein DJ, Mickelson DJ, Oegema TR, Furcht LT, McCarthy JB: Cell surface phosphatidylinositol-anchored heparan sulfate proteoglycan initiates mouse melanoma cell adhesion to a fibronectin-derived, heparin-binding synthetic peptide. J Cell Biol 117:1331-1341, 1992
15. Engvall E, Ruoslahti E: Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer 20:1-5, 1977
16. Faassen AE, Mooradian DL, Tranquillo RT, Dickinson RB, Letourneau PC, Oegema TR, McCarthy JB: Cell surface CD44-relatcd chondroitin sulfate proteoglycan is required for transforming growth factor-β-stimulated mouse melanoma cell motility and invasive behavior on type 1 collagen. J Cell Sci 105:501-511, 1993
17. Folkvord JM, Viders D, Coleman-Smith A, Clark RAF: Optimization of immunohistochemical techniques to detect extracellular matrix proteins in fixed skin specimens. J Histochem Cytochem 37:105-113, 1989
18. Gailit J, Pierschbacher M, Clark RAF: Expression of functional α4β1 by human dermal fibroblasts. J Invest Dermatol 100:323-328, 1993
19. Gailit J, Xu J, Bueller H, Clark RAF: Platelet-derived growth factor and inflammatory cytokines have differential effects on the expression of integrins α1β1 and α5β1 by human dermal fibroblasts in vitro. J Cell Physiol 169: 281-289, 1996
20. Greiling D, Clark RAF: Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J Cell Sci 110: 861-870, 1997
21. Grinnell F, Ho CH, Wysocki AJ: Degradation of fibronectin and vitronectin in chronic wound fluid: Analysis by cell blotting, immunoblotting, and cell adhesion assays. J Invest Dermatol 98:410-416, 1992
22. Grinnell F, Zhu M: Identification of neutrophil elastase as the proteinase in burn wound fluid responsible for degradation of fibronectin. J Invest Dermatol 103:155-161, 1994
23. Guan JL, Hynes RO: Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor α4β1. Cell 60:53-61, 1990
24. Hautanen A, Gailit J, Mann DM, Ruoslahti E: Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor. J Biol Chem 264:1437-1442, 1989
25. Herrick SE, Sloan P, McGurk M, Freak L, McCollum CN, Ferguson MWJ: Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Pathol 141:1085-1095, 1992
26. Huebsch JC, McCarthy JB, Diglio CA, Mooradian DL: Endothelial cell interactions with synthetic peptides from the carboxyl-terminal heparin-binding domains of fibronectin. Circ Res 77:43-53, 1995
27. Huhtala P, Humphries MJ, McCarthy JB, Tremble PM, Werb Z, Damsky CH: Cooperative signaling by α5β1 and α4β1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 129:867-879, 1995
28. Humphries MJ, Akiyama S, Komoriya A, Olden K, Yamada KM: Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific interaction. J Cell Biol 103:2637-2647, 1986
29. Humphries MJ, Akiyama SK, Komoriya A, Olden K, Yamada KM: Identification of two distinct regions of the type III connecting segment of human plasma fibronectin that promote cell type-specific adhesion. J Biol Chem 262: 6886-6892, 1987
30. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11-25, 1992
31. Iida J, Skubitz AP, Furcht LT, Wayner EA, McCarthy JB: Coordinate role for cell surface chondroitin sulfate proteoglycan and α4β1 integrin in mediating melanoma cell adhesion to fibronectin. J Cell Biol 118:431-444, 1992
32. Ingham KC, Brew SA, Migliorini MM, Busby TF: Binding of heparin by type III domains and peptides from the carboxy terminal hep-2 region of fibronectin. Biochemistry 32:12548-12553, 1993
33. Komoriya A, Green LJ, Mervic M, Yamada SS, Yamada KM, Humphries MJ: The minimal essential sequence for a major cell type-specific adhesion site (CS 1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine. J Biol Chem 266:15075-15079, 1991
34. Maheshwari G, Brown G, Lauffenburger DA, Wells A, Griffith LG: Cell adhesion and motility depend on nanoscale RGD clusterin. J Cell Sci 113: 1677-1686, 2000g
35. Massia SP, Hubbell JA: Vascular endothelial cell adhesion and spreading promoted by the peptide REDV of the IIICS region of plasma fibronectin is mediated by the integrin α4β1. J Biol Chem 267:14019-14026, 1992
36. McCarthy JB, Chelberg MK, Mickelson DJ, Furcht LT: Localization and chemical synthesis of fibronectin peptides with melanoma adhesion and heparin binding activities. Biochemistry 27:1380-1388, 1988
37. McCarthy JB, Chelberg MK, Mickelson DJ, Furcht LT: RGD-independent cell adhesion to the carboxy-terminal heparin binding fragment of fibronectin involves heparin-dependent and -independent activities. J Cell Biol 110:777-787, 1990
38. McClain SA, Simon M, Jones E, et al: Mesenchymal cell activation is the rate-limiting step of granulation tissue induction. Am J Pathol 149:1257-1270, 1996
39. Mooradian DL, McCarthy JB, Cameron JD, Skubitz APN, Furcht LT: Rabbit corneal epithelial cells adhere to two distinct heparin-binding synthetic peptides derived from fibronectin. Invest Ophthalmol Vis Sci 33:3034-3040, 1992
40. Mooradian DL, McCarthy JB, Skubitz APN, Cameron JD, Furcht LT: Characterization of FN-C/H-V, a novel synthetic peptide from fibronectin that promotes rabbit corneal epithelial cell adhesion, spreading, and motility. Invest Ophthalmol Vis Sci 34:153-164, 1993
41. Mould AP, Askari JA, Craig SU, Garratt AN, Clements J, Humphries MJ: Integrin α4β1-mediated melanoma cell adhesion and migration on vascular cell adhesion molecule-1 (VCAM-1) and the alternatively spliced IIICS region of fibronectin. J Biol Chem 269:27224-27230, 1994
42. Mould AP, Humphries MJ: Identification of a novel recognition for the integrin α4β1 in the COOH-terminal heparin-binding domain of fibronectin. EMBO J 10:4089-4095, 1991
43. Mould AP, Komoriya A, Yamada KM, Humphries MJ: The CS5 peptide is a second site in the IIICS region of fibronectin recognized by the integrin α4β1. J Biol Chem 266:3579-3585, 1991
44. Nagai T, Yamakawa N, Aota S-I, Yamada SS, Akiyama SK, Olden K, Yamada KM: Monoclonal antibody characterization of two distant sites required for function of the central cell-binding domain of fibronectin in cell adhesion, cell migration, and matrix assembly. J Cell Biol 114:1295-1305, 1991
45. Obara M, Knag MS, Yamada KM: Site-directed mutagenesis of the cell-binding domain of fibronectin: Separable, synergistic sites mediate adhesive function. Cell 53:649-657, 1988
46. Pierschbacher MD, Ruoslahti E: Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309: 30-33, 1984
47. Pytela R, Pierschbacher MD, Ruoslahti E: Identification and isolation of a 140 kD cell surface glycoprotein with properties expected of a fibronectin receptor. Cell 40:191-198, 1985
48. Ramos JW, DeSimone DW: Xcnopus embryonic cell adhesion to fibronectin: Position-specific activation of RGD/synergy site-dependent migratory behavior at gastrulation. J Cell Biol 134:227-240, 1996
49. Ruoslahti E: Fibronectin and its receptors. Annu Rev Biochem 57:375-423, 1988
50. Ruoslahti E, Pierschacher MD: New perspectives in cell adhesion: RGD and integtins. Science 238:291-297, 1987
51. Sharma A, Askari JA, Humphries MJ, Jones EY, Stuart DI: Crystal structure of a heparin- and integrin-binding segment of human fibronectin. EMBO J 18:1468-1479, 1999
52. Skorstengaard K, Thogersen HC, Vibe-Pedersen K, PetersenTE, Magnusson S: Purification of twelve cyanogen bromide fragments from bovine plasma fibronectin and the amino acid sequence of eight of them: Overlap evidence aligning two plasmic fragmenys, internal homology in gelatin-binding region and phosphorylation site near C terminus. Eur J Biochem 128:605-623, 1982
53. Tuszynski GP, Murphy A: Spectrophotometric quantitation of anchorage-dependent cell numbers using the bicinchoninic acid protein assay reagent. Anal Biochem 184:189-191, 1990
54. Varani J, Orr W, Ward PA: Comparison of the migration patterns of normal and malignant cells in two assay systems. Am J Pathol 90:159-172, 1978
55. Wayner EA, Carter WG: Identification of multiple cell adhesion receptors for type VI collagen and fibronectin in human fibrosarcoma cells possessing unique α and common β subunits. J Cell Biol 105:1873-1884, 1987
56. Wayner EA, Carter WG, Piotrowicz R, Kunicki TJ: The function of multiple extracellular matrix receptors (ECMRs) in mediating cell adhesion to ECM. Preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic/IIa. J Cell Biol 107:1881-1891, 1988
57. Wayner EA, Garcia-Pardo A, Humphries MJ, McDonald JA, Carter WG: Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J Cell Biol 109:1321-1330, 1989
58. Wayner EA, Kovach NL: Activation-dependent recognition by hematopoietic cells of the LDV sequence in the V region of fibronectin. J Cell Biol 116:489-497, 1992
59. Welch MP, Odland GF, Clark RAF: Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol 110:133-145, 1990
60. Wilke MS, Skubitz APN, Furcht LT, McCarthy JB: Human keratinocytes adhere to two distinct heparin binding synthetic peptides derived from fibronectin. J Invest Dermatol 97:573-579, 1991
61. Wilke MS, Vespa J, Skubitz APN, Furcht LT, McCarthy JB: Human keratinocytes adhere to and spread on synthetic peptide FN-C/H-V derived from fibronectin. J Invest Dermatol 101:43-48, 1993
62. Woods A, Couchman JR, Hook M: Adhesion and cytoskeletal organization of fibroblasts in response to fibronectin fragments. EMBO J 5:665-670, 1986
63. Woods A, McCarthy JB, Furcht LT, Couchman JR: A synthetic peptide from the COOH-terminal heparin binding domain of fibronectin promotes focal adhesion formation. Mol Biol Cell 4:605-613, 1993
64. Wysocki AB, Staiano-Coico L, Grinnell F: Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 101:64-68, 1993
65. Xu J, Clark RAF: Extracellular matrix alters PDGF regulation of fibroblast integrins.J Cell Biol 132:239-249, 1996
66. Yamada KN: Fibronectin and other cell interactive glycoproteins. In: Hay ED (ed.) Cell Biology of Extracellular Matrix. New York: Plenum Press, 1991; p 111-145
67. Yamada KM, Clark RAF: Provisional matrix. In: Clark R (ed.) Molecular and Cellular Biology of Wound Repair. New York: Plenum Press, 1996; p 51-93
68. Yamada KM, Kennedy DW: Dualistic nature of adhesive protein function: Fibronectin and its biologically active peptide fragments can autoinhibit fibronectin function. J Cell Biol 99:29-36, 1984